Patent Assignment
Reel/Frame 045908/0481
Security Interest
Recorded: 2018-05-27
Pages: 14
Assignor
ONCOLIX, INC.
Executed: 2018-05-25
Assignee
PURITAN PARTNERS LLC (AGENT)
369 LEXINGTON AVE., 25TH FLR, C/O CENTRE COURT ASSET MGMT, NEW YORK, NEW YORK, 10117
Covered Properties
(9)
Bi-Functional Cancer Treatment Agents
Use of Anti-Prolactin Agents to Treat Proliferative Conditions
Multimeric Ligands with Enhanced Stability
Human Prolactin Antagonist-Angiogensis Inhibitor Fusion Proteins
Use of prolactin receptor antagonists in combination with an agent that inactivates the HER2/neu signaling pathway
Human Prolactin Antagonist-Angiogenesis Inhibitor Fusion Proteins
Compositions and Methods for Visualizing and Eliminating Cancer Stem Cells
Compositions and Methods for Visualizing and Eliminating Cancer Stem Cells
Method for Treating Cancers Expressing Prolactin Receptor
Application:
62/637,860 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 1, 2011
From: CHEN, WEN Y.
To: ONCOLIX, INC.
Reel/Frame 027152/0814 →
Assignment of Assignor's Interest
Jul 26, 2017
From: CHEN, WEN Y.
To: ONCOLIX, INC.
Reel/Frame 043105/0402 →
Security Interest
Aug 7, 2017
From: ADVANCED ENVIRONMENTAL PETROLEUM PRODUCERS, INC.; ONCOLIX, INC.
To: PURITAN PARTNERS LLC
Reel/Frame 043214/0671 →
Assignment of Assignor's Interest
Mar 20, 2018
From: PAYNE, JAMES DONALD
To: ONCOLIX, INC.
Reel/Frame 045287/0151 →